The presentation will provide a review of canine sedation, particularly the physiology of alpha-2 receptors and the pharmacology of alpha-2 adrenoreceptor agonists and their reversal. It will also introduce the unique new alpha-2 combination product, Zenalpha, containing the alpha-2 agonist medetomidine and the peripherally selective alpha-2 antagonist vatinoxan. Attendees will learn about the innovative mechanism of action of Zenalpha and how this provides unique benefits, including reduced cardiovascular side effects during sedation.
- The physiology of alpha-2 receptors and that the location of the receptor influences its effect
- The basic pharmacology of alpha-2 agonists and antagonists
- How Zenalpha works, how to use it, what benefits it can bring, to canine patients and the team
Presented at London Vet Show 2022
Please note this session is not RACE-approved but you can still earn a CPD certificate